Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,170 | 579 | 98.9% |
| Education | $142.55 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,462 | 179 | $0 (2024) |
| Janssen Biotech, Inc. | $2,712 | 114 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,254 | 67 | $0 (2024) |
| Celgene Corporation | $808.65 | 45 | $0 (2024) |
| Lilly USA, LLC | $545.96 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $469.27 | 23 | $0 (2024) |
| PFIZER INC. | $460.27 | 27 | $0 (2024) |
| Gilead Sciences, Inc. | $335.73 | 19 | $0 (2023) |
| GENZYME CORPORATION | $263.72 | 6 | $0 (2024) |
| QOL Medical, LLC | $247.10 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,723 | 100 | ABBVIE INC. ($746.87) |
| 2023 | $2,998 | 105 | AbbVie Inc. ($984.24) |
| 2022 | $2,122 | 93 | ABBVIE INC. ($893.41) |
| 2021 | $1,633 | 82 | AbbVie Inc. ($569.61) |
| 2020 | $814.38 | 34 | AbbVie Inc. ($454.93) |
| 2019 | $660.58 | 47 | Janssen Biotech, Inc. ($134.60) |
| 2018 | $1,288 | 66 | AbbVie, Inc. ($335.84) |
| 2017 | $1,074 | 56 | AbbVie, Inc. ($404.83) |
All Payment Transactions
583 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $143.21 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Immunology | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 847 | 902 | $528,324 | $108,077 |
| 2022 | 16 | 1,041 | 1,103 | $631,564 | $132,252 |
| 2021 | 10 | 889 | 951 | $571,110 | $123,708 |
| 2020 | 14 | 834 | 937 | $448,049 | $108,729 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 177 | 178 | $216,920 | $40,999 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 222 | $47,497 | $15,656 | 33.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 130 | 133 | $108,254 | $12,636 | 11.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 56 | $21,683 | $8,609 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $29,456 | $7,944 | 27.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 61 | $12,377 | $6,434 | 52.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $36,244 | $3,444 | 9.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $16,650 | $3,296 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 29 | $8,327 | $3,055 | 36.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $20,595 | $2,807 | 13.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 19 | $2,705 | $1,333 | 49.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,624 | $906.33 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,266 | $904.00 | 39.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 12 | 12 | $2,726 | $51.78 | 1.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 212 | 213 | $262,303 | $46,137 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 262 | 298 | $63,757 | $23,131 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 170 | 170 | $55,639 | $15,247 | 27.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 125 | 126 | $102,887 | $11,164 | 10.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 37 | $14,326 | $6,471 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 42 | $12,059 | $5,635 | 46.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 19 | 19 | $17,952 | $3,804 | 21.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $22,512 | $3,704 | 16.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 40 | $8,116 | $3,612 | 44.5% |
| 43270 | Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 19 | $13,701 | $3,496 | 25.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 15 | 15 | $13,875 | $2,983 | 21.5% |
About Dr. Susie Cohn, MD
Dr. Susie Cohn, MD is a Gastroenterology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205161130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susie Cohn, MD has received a total of $13,313 in payments from pharmaceutical and medical device companies, with $2,723 received in 2024. These payments were reported across 583 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($13,170).
As a Medicare-enrolled provider, Cohn has provided services to 3,611 Medicare beneficiaries, totaling 3,893 services with total Medicare billing of $472,766. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Oakland, CA
- Active Since 10/09/2009
- Last Updated 11/20/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205161130
Products in Payments
- STELARA (Biological) $2,229
- RINVOQ (Biological) $1,166
- ENTYVIO (Biological) $981.61
- HUMIRA (Biological) $936.79
- ZEPOSIA (Drug) $933.58
- SKYRIZI (Biological) $814.33
- OMVOH (Drug) $522.16
- Mavyret (Drug) $391.92
- TREMFYA (Drug) $372.14
- XELJANZ (Drug) $334.68
- MAVYRET (Drug) $301.23
- DUPIXENT (Biological) $289.25
- LINZESS (Drug) $268.14
- Entyvio (Biological) $261.84
- TRULANCE (Drug) $226.57
- REMICADE (Biological) $221.73
- OCALIVA (Drug) $204.81
- Humira (Biological) $187.01
- XIFAXAN (Drug) $176.94
- CREON (Drug) $174.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakland
Dr. Neil Stollman, Md, MD
Gastroenterology — Payments: $171,798
Ralph Peterson, Md, MD
Gastroenterology — Payments: $129,890
Dr. Liana Vesga, Md, MD
Gastroenterology — Payments: $12,795
Dr. Silvia Villagomez, Md, MD
Gastroenterology — Payments: $11,402
Dr. Earl Darby, Md, MD
Gastroenterology — Payments: $5,922
Dr. Paul Chard, Md Phd, MD PHD
Gastroenterology — Payments: $4,744